GMM Pfaudler reported solid FY26 results with consolidated revenue up 10% YoY to ₹3,524 Cr and EBITDA growing 11% to ₹403 Cr.

Q4 saw strong revenue growth of 17% YoY to ₹944 Cr and PAT surged 155% to ₹15 Cr.

India operations showed impressive performance, with revenue up 12% to ₹1,034 Cr and PAT rising 40% for FY26. The company's diversification strategy is gaining momentum, with a balanced focus across Traditional, Pharmaceuticals, and Chemicals sectors contributing to order intake.

Consolidated order intake jumped 20% to ₹3,714 Cr, boosting the backlog by 34% YoY to ₹2,194 Cr.

Consolidated EPS for FY26 rose 9% to ₹12.86. Key leadership appointments include Gregory Gelhaus as Group CEO and Ankit Nayyar as Deputy CFO.

The company declared a final dividend of ₹1 per share, bringing the total FY26 dividend to ₹2 per share.

The robust order book and strategic diversification across sectors indicate positive momentum and future growth alignment.